Why the study?
Does Phenylindanedione alter prothrombin time similarly to dicoumarol in the treatment of thrombosis?
Does Phenylindanedione alter prothrombin time similarly to dicoumarol in the treatment of thrombosis?
Phenylindanedione is an effective anticoagulant that alters prothrombin time more rapidly and for a shorter duration than dicoumarol.
Answers are grounded in this paper and cite their sources.
May inform anticoagulant timing considerations; leaves open prospective validation versus modern agents.
(P.I.D.) was an anticoagulant whicheffectively altered theone-stage prothrombin timeithasbeenusedextensively in thetreatment ofcasesofthrombosis (Blaustein, 1950;Blaustein, Shnayerson, andWallach, 1953; Dennis, Coon,Hodgson, andDuff, 1952;Toohey, 1953). Clinically itappears toproduce thesame effect asdicoumarol, butitsaction ismorerapid and lessprolonged (Blaustein, 1950;Jaques, Gordon,and Lepp,1950;Bjerkelund, 1950). Sufficient experience hasnotyetbeenaccumulated tocompareitsefficacy withthatoftromexan (ethyl-biscoumacetate),
No takes yet. Share an insight, caveat, or question.
Walker et al. (1954) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: